Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 4PBU | Q9F1R6 | Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state | |
| 4PBU | Q8DJI1 | Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state | |
| 4PBU | Q8DHJ2 | Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state | |
| 4PBG | P11546 | 6-PHOSPHO-BETA-GALACTOSIDASE FORM-CST | |
| 4PB2 | Q9KPL5 | Structure of vcCNT-7C8C bound to 5-fluorouridine | |
| 4PB1 | Q9KPL5 | Structure of vcCNT-7C8C bound to ribavirin | |
| 4P9M | 4P9M | Crystal structure of 8ANC195 Fab | |
| 4P9H | P01730 | Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2 | |
| 4P9H | Q0ED31 | Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2 | |
| 4P9H | 4P9H | Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2 | |
| 4P99 | 4P99 | Ca2+-stabilized adhesin helps an Antarctic bacterium reach out and bind ice | |
| 4P91 | Q80WD1 | Crystal structure of the nogo-receptor-2 (27-330) | |
| 4P8X | Q15782 | The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc6) were solved to resolutions of 2.48 angstrom | |
| 4P8W | Q15782 | The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc4) were solved to resolutions of 1.9 angstrom | |
| 4P8V | Q15782 | The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc2) were solved to resolutions of 1.5 angstrom | |
| 4P8S | Q80WD1 | Crystal structure of Nogo-receptor-2 | |
| 4P8Q | Q9UIQ6 | Crystal Structure of Human Insulin Regulated Aminopeptidase with Alanine in Active Site | |
| 4P8E | Q9KKP2 | Structure of ribB complexed with substrate (Ru5P) and metal ions | |
| 4P7R | P75906 | Structure of Escherichia coli PgaB C-terminal domain in complex with a poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) hexamer | |
| 4P7Q | P75906 | Structure of Escherichia coli PgaB C-terminal domain in complex with N-acetylglucosamine | |
| 4P7N | P75906 | Structure of Escherichia coli PgaB C-terminal domain in complex with glucosamine | |
| 4P77 | Q9KKP2 | Structure of ribB complexed with substrate Ru5P | |
| 4P6A | Q9KWN0 | Crystal structure of a potent anti-HIV lectin actinohivin in complex with alpha-1,2-mannotriose | |
| 4P5Y | Q0TRJ3 | Structure of CBM32-3 from a family 31 glycoside hydrolase from Clostridium perfringens in complex with N-acetylgalactosamine | |
| 4P5M | P20036 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P5M | Q5EP54 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P5M | 4P5M | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P5M | Q5EP54 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P5M | 4P5M | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P5I | Q2F862 | Crystal structure of the chemokine binding protein from orf virus | |
| 4P59 | P21860 | HER3 extracellular domain in complex with Fab fragment of MOR09825 | |
| 4P59 | 4P59 | HER3 extracellular domain in complex with Fab fragment of MOR09825 | |
| 4P57 | P20036 | MHC TCR peptide complex | |
| 4P57 | Q5EP54 | MHC TCR peptide complex | |
| 4P57 | 4P57 | MHC TCR peptide complex | |
| 4P57 | Q5EP54 | MHC TCR peptide complex | |
| 4P57 | 4P57 | MHC TCR peptide complex | |
| 4P4R | P20036 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P4R | P04440 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P4R | 4P4R | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P4R | P04440 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P4R | 4P4R | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between Allergic Hypersensitivity and Autoimmunity | |
| 4P4K | P20036 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity and auto immunity | |
| 4P4K | 4P4K | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity and auto immunity | |
| 4P4K | P04440 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity and auto immunity | |
| 4P4K | 4P4K | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity and auto immunity | |
| 4P4K | P04440 | Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity and auto immunity | |
| 4P4J | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33D | glutamate carboxypeptidase II (E.C.3.4.17.21) |
| 4P4I | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33 | glutamate carboxypeptidase II (E.C.3.4.17.21) |
| 4P4F | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor NC-2-40 | glutamate carboxypeptidase II (E.C.3.4.17.21) |
